EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides

Montserrat Goles iD, Anamaría Daza iD, Gabriel Cabas-Mora iD, Lindybeth Sarmiento-Varón iD, Julieta Sepúlveda-Yañez iD, Hoda Anvari-Kazemabad iD, Mehdi D Davari iD, Roberto Uribe-Paredes iD, Álvaro Olivera-Nappa iD, Marcelo A Navarrete iD, David Medina-Ortiz iD

Briefings in Bioinformatics · 23.05.2024 · 25 (4)

DOI: 10.1093/bib/bbae275 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 10.06.2024. Verfasst von Montserrat Goles und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ingeniería en Computación, Universidad de Magallanes, Av. Pdte. Manuel Bulnes 01855, 6210427, Punta Arenas, Chile. Hauptthemen laut MEDLINE: Artificial Intelligence, Peptides, Drug Discovery. Die Arbeit wurde bisher 186-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SUBVENCIÓN A INSTALACIÓN EN LA ACADEMIA CONVOCATORIA AÑO 2022, Centre for Biotechnology and Bioengineering, Fondecyt project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With their diverse biological activities, peptides are promising candidates for therapeutic applications, showing antimicrobial, antitumour and hormonal signalling capabilities. Despite their advantages, therapeutic peptides face challenges such as short half-life, limited oral bioavailability and susceptibility to plasma degradation. The rise of computational tools and artificial intelligence (AI) in peptide research has spurred the development of advanced methodologies and databases that are pivotal in the exploration of these complex macromolecules. This perspective delves into integrating AI in peptide development, encompassing classifier methods, predictive systems and the avant-garde design facilitated by deep-generative models like generative adversarial networks and variational autoencoders. There are still challenges, such as the need for processing optimization and careful validation of predictive models. This work outlines traditional strategies for machine learning model construction and training techniques and proposes a comprehensive AI-assisted peptide design and validation pipeline. The evolving landscape of peptide design using AI is emphasized, showcasing the practicality of these methods in expediting the development and discovery of novel peptides within the context of peptide-based drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligencePeptidesDrug DiscoveryHumansDrug DesignMachine LearningComputational Biology

Stichwörter der Autor:innen

artificial intelligencedeep generative modelsdeep learninglarge language modelspeptide-base drug discoveryprotein engineeringtherapeutic peptides

Substanzen

Peptides

Autor:innen und Institutionen

  • Departamento de Ingeniería en Computación, Universidad de Magallanes, Av. Pdte. Manuel Bulnes 01855, 6210427, Punta Arenas, Chile.
  • Departamento de Ingeniería Química, Biotecnología y Materiales, Universidad de Chile, Beauchef 851, 8370456, Santiago, Chile.
  • Centre for Biotechnology and Bioengineering, CeBiB, Universidad de Chile, Beauchef 851, 8370456, Santiago, Chile.
  • Centro Asistencial de Docencia e Investigación, CADI, Universidad de Magallanes, Av. Los Flamencos 01364, 6210005, Punta Arenas, Chile.
  • Facultad de Ciencias de la Salud, Universidad de Magallanes, Av. Pdte. Manuel Bulnes 01855, 6210427, Punta Arenas, Chile.
  • Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120, Halle, Germany.

ORCID-Profile: Montserrat Goles, Anamaría Daza, Gabriel Cabas-Mora, Lindybeth Sarmiento-Varón, Julieta Sepúlveda-Yañez, Hoda Anvari-Kazemabad, Mehdi D Davari, Roberto Uribe-Paredes, Álvaro Olivera-Nappa, Marcelo A Navarrete, David Medina-Ortiz

Förderung

  • SUBVENCIÓN A INSTALACIÓN EN LA ACADEMIA CONVOCATORIA AÑO 2022
  • Centre for Biotechnology and Bioengineering
  • Fondecyt project
  • ANID
  • Deutsche Forschungsgemeinschaft
  • Priority Program Molecular Machine Learning SPP2363

Zitieren

APA

Goles, M., Daza, A., Cabas-Mora, G., Sarmiento-Varón, L., Sepúlveda-Yañez, J., Anvari-Kazemabad, H., Davari, M. D., Uribe-Paredes, R., Olivera-Nappa, Á., Navarrete, M. A., & Medina-Ortiz, D. (2024). Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides. Briefings in Bioinformatics, 25(4). https://doi.org/10.1093/bib/bbae275

Vancouver

Goles M, Daza A, Cabas-Mora G, Sarmiento-Varón L, Sepúlveda-Yañez J, Anvari-Kazemabad H, et al. Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides. Briefings in Bioinformatics. 2024;25(4). doi:10.1093/bib/bbae275

BibTeX
@article{Goles2024,
  author = {Goles, Montserrat and Daza, Anamaría and Cabas-Mora, Gabriel and Sarmiento-Varón, Lindybeth and Sepúlveda-Yañez, Julieta and Anvari-Kazemabad, Hoda and Davari, Mehdi D and Uribe-Paredes, Roberto and Olivera-Nappa, Álvaro and Navarrete, Marcelo A and Medina-Ortiz, David},
  title = {Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides},
  journal = {Briefings in Bioinformatics},
  year = {2024},
  volume = {25},
  number = {4},
  doi = {10.1093/bib/bbae275}
}
Kostenlos starten →